Primary Hyperlipidemia
Also known as: Familial hyperlipidemia / Familial hyperlipidaemia / Fredrickson's hyperlipoproteinemia, type IIa / Type IIa hyperlipoproteinemia / Hyperlipoproteinemia Type IIa / Fredrickson Type IIa hyperlipoproteinemia / Fredrickson type IIa hyperlipoproteinemia (disorder) / Familial hypercholesterolemia (disorder) / Type IIa hyperlipoproteinaemia / Fredrickson Type IIa hyperlipoproteinaemia / Fredrickson Type IIa hyperlipidemia / Fredrickson Type IIa hyperlipidaemia / Fredrickson Type IIa lipidemia / (Hypercholesterolaemia: [pure] or [familial]) or (Fredrickson type IIa lipidaemia) or (low density lipoproteinaemia) / Fredrickson Type IIa lipidaemia / Type IIa hyperlipidaemia / Type IIa hyperlipidemia
Drug | Drug Name | Drug Description |
---|---|---|
DB09302 | Alirocumab | A PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C). |
DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
DB00930 | Colesevelam | A bile acid sequestrant used to lower LDL-C in adults with hyperlipidemia and pediatric patients with heterozygous familial hypercholesterolemia, and to improve glycemic control in type 2 diabetes. |
DB09303 | Evolocumab | A PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures. |
DB00973 | Ezetimibe | A cholesterol absorption inhibitor used to lower total cholesterol, LDL-C, Apo-B, and non-HDL-C in primary hyperlipidemia and familial cholesterolemia. |
DB08860 | Pitavastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
DB01098 | Rosuvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
Drug | Drug Name | Phase | Status | Count |
---|